HORMAD1 is the best studied of these meiotic cancer genes and it is well established that HORMAD1 expression correlates with an increase in mutation burden, neo-antigen production, and gross chromosomal abnormalities in cancer (39, 40, 43, 44). This evidence concerns the gene HORMAD1 and cancer.